Sandi – US: Multiple Sclerosis (LDN; low dose naltrexone)

  Welcome to the LDN Radio Show brought to you by the LDN Research Trust. I’m your host Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining […]

The role of immune modulation and anti-inflammatory agents in the management of prostate cancer… (Abstract)

The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients Oncol Lett 07 June 2022 https://pubmed.ncbi.nlm.nih.gov/35761946/ Cancer is associated with chronic inflammation and disruption to normal immune function. As such, the ability to thrive in a chronically inflamed microenvironment is regarded as a hallmark of […]

LDN Webinar 18 May 2022 (LDN; low dose naltrexone)

  LDN Webinar 18 May 2022 (LDN; low dose naltrexone) LDN Questions Answered Live by Pharmacist Dr Masoud Rashidi – LDN Specialist Dr Sato-Re Dr Mathewson Sponsored by Innovative Compounding Pharmacy icpfolsom.com